Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013

Abstract

The adoption of novel treatments in MM in Finland has had substantial impact on patient outcomes. Given the reality of complex treatment combinations for MM and relatively low patient numbers, assessing individual treatment effectiveness will require substantial cohort sizes and advanced, collaborative analytics on an international scale.